Search - tctmd.com

Displaying 141 - 160 of 335

Sort: Relevancy | Date

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Presentation TCT 2020

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

Presenter: A D S P K Athukorala

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Presentation TCT 2020

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

Presenter: Bernardo Cortese

October 14, 2020

Presentation TCT 2020

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 14, 2020

Presentation TCT 2020

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Presenter: Matthias Lutz

October 14, 2020

Presentation

“Is Sirolimus the new concept for Drug Coated Balloon?”

Presenter: Bernardo Cortese

February 13, 2020

Presentation TCT 2019

Sirolimus-Coated Balloon Therapy: State of Development

Presenter: Stefan Verheye

September 28, 2019

Presentation TCT 2019

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Presenter: Giuseppe Sangiorgi

September 28, 2019

Presentation TCT 2019

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Presenter: Sreekala Padmanabhan

September 28, 2019

Presentation TCT 2019

Xtreme FIM: Clinical Outcome and Safety in Peripheral Vascular Disease With Sirolimus-Coated Balloon (And Case Report)

Presenter: Sameer Dani

September 28, 2019

Presentation TCT 2019

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

Presenter: Edward Choke

September 28, 2019

Presentation TCT 2019

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Presenter: Aloke Finn

September 28, 2019

Presentation TCT 2019

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

Presenter: George Dangas

September 28, 2019

Presentation TCT 2019

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

Presenter: Manel Sabate

September 27, 2019

Presentation TCT 2019

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Presenter: Sahil Parikh

September 27, 2019

Presentation TCT 2019

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

Presenter: Sriram Iyer

September 27, 2019

Advertisement

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

“Is Sirolimus the new concept for Drug Coated Balloon?”

Sirolimus-Coated Balloon Therapy: State of Development

Sirolimus-Coated Balloon for the Treatment of Vasculogenic Erectile Dysfunction: Ready for the Prime Time

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Xtreme FIM: Clinical Outcome and Safety in Peripheral Vascular Disease With Sirolimus-Coated Balloon (And Case Report)

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

12-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Arteries Below the Knee

Perivascular Sirolimus for Prevention of Dialysis Access Failure: Sirogen Technology Overview and Early Human Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content